| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $975.2M | +48.6% |
| Cost of Revenue | $232.6M | +58.1% |
| Gross Profit | $742.6M | +45.8% |
| R&D Expense | $298.3M | +57.5% |
| SG&A Expense | $179.8M | +50.4% |
| Operating Income | -$201.2M | -57.6% |
| Interest Expense | $5.0M | -89.9% |
| Pre-tax Income | -$190.7M | +23.1% |
| Income Tax | $2.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $204.2M | -34.9% |
| Accounts Receivable | $148.5M | +55.5% |
| Current Assets | $1.89B | -3.5% |
| Total Assets | $2.59B | +9.1% |
| Current Liabilities | $397.9M | +37.9% |
| Total Liabilities | $1.96B | +26.2% |
| Stockholders' Equity | $624.0M | -23.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $123.6M | +91.2% |
| Capital Expenditures | $143.6M | +54.4% |
| Investing Cash Flow | -$235.7M | +66.8% |
| Financing Cash Flow | $6.3M | -99.3% |
| Free Cash Flow | -$20.0M | +29.4% |
| -78.5% |
| Net Income | -$193.4M | +25.7% |
| EPS (Basic) | -$0.59 | +28.9% |
| EPS (Diluted) | -$0.59 | +28.9% |